191 related articles for article (PubMed ID: 17563123)
1. Controlled peptide solvation in portion-mixing libraries of FRET peptides: improved specificity determination for Dengue 2 virus NS2B-NS3 protease and human cathepsin S.
Alves FM; Hirata IY; Gouvea IE; Alves MF; Meldal M; Brömme D; Juliano L; Juliano MA
J Comb Chem; 2007; 9(4):627-34. PubMed ID: 17563123
[TBL] [Abstract][Full Text] [Related]
2. Probing the substrate specificity of the dengue virus type 2 NS3 serine protease by using internally quenched fluorescent peptides.
Niyomrattanakit P; Yahorava S; Mutule I; Mutulis F; Petrovska R; Prusis P; Katzenmeier G; Wikberg JE
Biochem J; 2006 Jul; 397(1):203-11. PubMed ID: 16489931
[TBL] [Abstract][Full Text] [Related]
3. Substrate specificity of recombinant dengue 2 virus NS2B-NS3 protease: influence of natural and unnatural basic amino acids on hydrolysis of synthetic fluorescent substrates.
Gouvea IE; Izidoro MA; Judice WA; Cezari MH; Caliendo G; Santagada V; dos Santos CN; Queiroz MH; Juliano MA; Young PR; Fairlie DP; Juliano L
Arch Biochem Biophys; 2007 Jan; 457(2):187-96. PubMed ID: 17184724
[TBL] [Abstract][Full Text] [Related]
4. Japanese encephalitis virus NS2B-NS3 protease binding to phage-displayed human brain proteins with the domain of trypsin inhibitor and basic region leucine zipper.
Lin CW; Lin KH; Lyu PC; Chen WJ
Virus Res; 2006 Mar; 116(1-2):106-13. PubMed ID: 16289409
[TBL] [Abstract][Full Text] [Related]
5. Competitive inhibition of the dengue virus NS3 serine protease by synthetic peptides representing polyprotein cleavage sites.
Chanprapaph S; Saparpakorn P; Sangma C; Niyomrattanakit P; Hannongbua S; Angsuthanasombat C; Katzenmeier G
Biochem Biophys Res Commun; 2005 May; 330(4):1237-46. PubMed ID: 15823576
[TBL] [Abstract][Full Text] [Related]
6. The active essential CFNS3d protein complex.
Melino S; Fucito S; Campagna A; Wrubl F; Gamarnik A; Cicero DO; Paci M
FEBS J; 2006 Aug; 273(16):3650-62. PubMed ID: 16911516
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the West Nile virus protease substrate specificity and inhibitors.
Mueller NH; Yon C; Ganesh VK; Padmanabhan R
Int J Biochem Cell Biol; 2007; 39(3):606-14. PubMed ID: 17188926
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and disulfide bond connectivity-activity studies of a kalata B1-inspired cyclopeptide against dengue NS2B-NS3 protease.
Gao Y; Cui T; Lam Y
Bioorg Med Chem; 2010 Feb; 18(3):1331-6. PubMed ID: 20042339
[TBL] [Abstract][Full Text] [Related]
9. Peptide inhibitors of Dengue virus NS3 protease. Part 1: Warhead.
Yin Z; Patel SJ; Wang WL; Wang G; Chan WL; Rao KR; Alam J; Jeyaraj DA; Ngew X; Patel V; Beer D; Lim SP; Vasudevan SG; Keller TH
Bioorg Med Chem Lett; 2006 Jan; 16(1):36-9. PubMed ID: 16246553
[TBL] [Abstract][Full Text] [Related]
10. Positional-scanning combinatorial libraries of fluorescence resonance energy transfer peptides to define substrate specificity of carboxydipeptidases: assays with human cathepsin B.
Cotrin SS; Puzer L; de Souza Judice WA; Juliano L; Carmona AK; Juliano MA
Anal Biochem; 2004 Dec; 335(2):244-52. PubMed ID: 15556563
[TBL] [Abstract][Full Text] [Related]
11. Binding specificity of polypeptide substrates in NS2B/NS3pro serine protease of dengue virus type 2: A molecular dynamics Study.
Yotmanee P; Rungrotmongkol T; Wichapong K; Choi SB; Wahab HA; Kungwan N; Hannongbua S
J Mol Graph Model; 2015 Jul; 60():24-33. PubMed ID: 26086900
[TBL] [Abstract][Full Text] [Related]
12. Cleavage preference distinguishes the two-component NS2B-NS3 serine proteinases of Dengue and West Nile viruses.
Shiryaev SA; Kozlov IA; Ratnikov BI; Smith JW; Lebl M; Strongin AY
Biochem J; 2007 Feb; 401(3):743-52. PubMed ID: 17067286
[TBL] [Abstract][Full Text] [Related]
13. Yellow fever virus NS2B/NS3 protease: hydrolytic properties and substrate specificity.
Kondo MY; Oliveira LC; Okamoto DN; de Araujo MR; Duarte dos Santos CN; Juliano MA; Juliano L; Gouvea IE
Biochem Biophys Res Commun; 2011 Apr; 407(4):640-4. PubMed ID: 21419753
[TBL] [Abstract][Full Text] [Related]
14. Proteochemometrics analysis of substrate interactions with dengue virus NS3 proteases.
Prusis P; Lapins M; Yahorava S; Petrovska R; Niyomrattanakit P; Katzenmeier G; Wikberg JE
Bioorg Med Chem; 2008 Oct; 16(20):9369-77. PubMed ID: 18824362
[TBL] [Abstract][Full Text] [Related]
15. Internally quenched fluorescent peptide libraries with randomized sequences designed to detect endopeptidases.
Oliveira LC; Silva VO; Okamoto DN; Kondo MY; Santos SM; Hirata IY; Vallim MA; Pascon RC; Gouvea IE; Juliano MA; Juliano L
Anal Biochem; 2012 Feb; 421(1):299-307. PubMed ID: 22067978
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus.
Erbel P; Schiering N; D'Arcy A; Renatus M; Kroemer M; Lim SP; Yin Z; Keller TH; Vasudevan SG; Hommel U
Nat Struct Mol Biol; 2006 Apr; 13(4):372-3. PubMed ID: 16532006
[TBL] [Abstract][Full Text] [Related]
17. Development of sensitive cathepsin G fluorogenic substrate using combinatorial chemistry methods.
Lesner A; Wysocka M; Guzow K; Wiczk W; Legowska A; Rolka K
Anal Biochem; 2008 Apr; 375(2):306-12. PubMed ID: 18261971
[TBL] [Abstract][Full Text] [Related]
18. Optimization of assay conditions for dengue virus protease: effect of various polyols and nonionic detergents.
Steuer C; Heinonen KH; Kattner L; Klein CD
J Biomol Screen; 2009 Oct; 14(9):1102-8. PubMed ID: 19726784
[TBL] [Abstract][Full Text] [Related]
19. Defining the substrate specificity of mouse cathepsin P.
Puzer L; Barros NM; Oliveira V; Juliano MA; Lu G; Hassanein M; Juliano L; Mason RW; Carmona AK
Arch Biochem Biophys; 2005 Mar; 435(1):190-6. PubMed ID: 15680921
[TBL] [Abstract][Full Text] [Related]
20. Peptide inhibitors of dengue virus NS3 protease. Part 2: SAR study of tetrapeptide aldehyde inhibitors.
Yin Z; Patel SJ; Wang WL; Chan WL; Ranga Rao KR; Wang G; Ngew X; Patel V; Beer D; Knox JE; Ma NL; Ehrhardt C; Lim SP; Vasudevan SG; Keller TH
Bioorg Med Chem Lett; 2006 Jan; 16(1):40-3. PubMed ID: 16246563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
